BBSRC invests £48m in Babraham Institute to advance lifelong health research The funding will help to support research across epigenetics, immunology and cell signalling
PlaqueTec and Babraham Institute partner for treatment of coronary heart disease CAD is responsible for around 68,000 deaths per year in the UK